Here are the portfolio’s top 5 performers in a record-setting week for stocks

The bulls got what they wanted this week: cooler inflation data and record highs. The Dow…

Promise of Eli Lilly’s weight-loss drug for sleep apnea adds another reason to own the stock

Eli Lilly ‘s weight-loss drug Zepbound showed promise as a treatment for sleep apnea — giving…

Health care has had a tough year. Where we stand on our 5 stocks in the sector

There’s Eli Lilly (LLY), and then there’s everybody else. That’s a simple way to describe the…

This health-care stock is set to complete another spin-off. Here’s what it means for our position in the stock

Medical equipment giant Danaher (DHR) will officially spin off its environmental-and-applied solutions segment later this month,…

Activists ease up on Salesforce — plus, 10 other Club stocks traded by Wall Street pros

The extraordinary activist-investor interest in Salesforce (CRM) eased further in the second quarter, according to the…

Here are the 5 price-target changes and 4 trades we made during this busy earnings week

In a jam-packed week of earnings, the Club executed multiple trades and elevated price targets for…

Newseum Global